NEWSROOM
MEDIA
ABBOTT INDIA LTD
PRODUCTS
CAREERS
ABOUT ABBOTT
Abbott has voluntarily recalled one batch (No. AEJ0713; Mfg. Date: March 2023) of Thyronorm, a medicine used in the treatment of hypothyroidism, in India, due to a labeling error that mislabeled the dose strength (mcg or microgram). We haven’t received any reports of patient impact.
We have also set up a helpline to address any queries or concerns of patients and the medical community. For any information or guidance, please contact Abbott at: +91 22 50461000 / 50462000 or webmasterindia@abbott.com
Published on April 27, 2023
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimized for your screen size.
Asset Warning